# A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis (PSC)

> **NCT02978339** · PHASE1,PHASE2 · COMPLETED · sponsor: **John E. Eaton** · enrollment: 15 (actual)

## Conditions studied

- Primary Sclerosing Cholangitis

## Interventions

- **DRUG:** Curcumin

## Key facts

- **NCT ID:** NCT02978339
- **Lead sponsor:** John E. Eaton
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-09
- **Primary completion:** 2018-11-16
- **Final completion:** 2019-01-08
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2020-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02978339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02978339, "A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis (PSC)". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT02978339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*